Biomay AG
Vienna, Austria
Program data pending ClinicalTrials.gov matching
· Last scored 2026-10-29
76.8
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
○ Press
✓ EMA GMP (12)
○ MHRA GMP
Quick Facts: Biomay AG
- Signal Score
- 76.8/100 (as of 2026-10-29)
- Quality Compliance
- 100.0/100 — Clean EMA record: 12 active GMP certificates (no deductions)
- Headquarters
- Vienna, Austria
- Modalities
- Plasmid
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Biomay AG
Pure-play CDMO.
Signal Score & Pillar Breakdown
Quality Compliance
100.0
Clean EMA record: 12 active GMP certificates (no deductions)
Sources: FDA Data Dashboard, EMA EudraGMDP
Clean EMA record: 12 active GMP certificates (no deductions)
FDA InspectionsNo US records on file
EMA GMP Certificates12 on record
Clean EMA record: 12 active GMP certificates (no deductions)
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesPlasmid
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
53.0
1 manufacturing site: Vienna, AT
Modalities: Plasmid
Capacity assessment: 53.0/100
Sites: Vienna, AT
Source: company profiles (manufacturing sites, modality breadth)
1 manufacturing site
1 manufacturing site: Vienna, AT
Modalities: Plasmid
Capacity assessment: 53.0/100
Biomay AG EMA GMP Compliance 12 certificates
2026-02
2025-10
2024-03
2024-03
2024-03
2024-03
2024-03
2023-11
2023-10
2022-03
2022-03
2021-04
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| 481719-104874335 | Biomay AG | Austria | 2026-02-19 | COMPLIANT |
| 484219-103674986 | Biomay AG | Austria | 2025-10-16 | COMPLIANT |
| 481719-104568656 | Biomay AG | Austria | 2024-03-13 | COMPLIANT |
| 481719-103425951 | Biomay AG | Austria | 2024-03-13 | COMPLIANT |
| 481719-102752478 | Biomay AG | Austria | 2024-03-13 | COMPLIANT |
| 481719-104874230 | Biomay AG | Austria | 2024-03-13 | COMPLIANT |
| 481719-102570085 | Biomay AG | Austria | 2024-03-13 | COMPLIANT |
| 484219-101573243 | Biomay AG | Austria | 2023-11-23 | COMPLIANT |
| 481719-101983357 | Biomay AG | Austria | 2023-10-11 | COMPLIANT |
| 484219-100395448 | Biomay AG | Austria | 2022-03-17 | COMPLIANT |
| 484219-102096252 | Biomay AG | Austria | 2022-03-17 | COMPLIANT |
| 481719-13693860 | Biomay AG | Austria | 2021-04-28 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Nov 21, 2026
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Nov 20, 2026
Frequently Asked Questions About Biomay AG
Does Biomay AG hold EMA or MHRA GMP certificates?
CDMO Signal tracks 12 EMA GMP certificates for Biomay AG.
What is Biomay AG's CDMO Signal Score?
Biomay AG has a Signal Score of 77/100, based on quality, operations, financial stability, and capacity data.
Evaluating Biomay AG for a manufacturing program?
Use the free AI matchmaker to compare Biomay AG against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Pharmaron
San Diego, CA · Shaoxing, China, Liverpool, UK, Ningbo China
Signal Score: 86.9
AAV, Lentiviral, Plasmid, mAb, Antibody, Recombinant Protein, Biosimilars
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 86.3
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
ReciBioPharm
Keele, UK · Sodertalje, SE
Signal Score: 82.9
AAV, Lentiviral, Plasmid, mRNA
Kaneka Eurogentec
Seraing, BE
Signal Score: 81.6
mRNA, Plasmid, Oligonucleotide
Aldevron
Fargo, ND
Signal Score: 80.3
Plasmid, mRNA
Compare Biomay AG with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.